AU2001237057A1 - Functionalized encapsulated fluorescent nanocrystals - Google Patents
Functionalized encapsulated fluorescent nanocrystalsInfo
- Publication number
- AU2001237057A1 AU2001237057A1 AU2001237057A AU3705701A AU2001237057A1 AU 2001237057 A1 AU2001237057 A1 AU 2001237057A1 AU 2001237057 A AU2001237057 A AU 2001237057A AU 3705701 A AU3705701 A AU 3705701A AU 2001237057 A1 AU2001237057 A1 AU 2001237057A1
- Authority
- AU
- Australia
- Prior art keywords
- functionalized
- fluorescent nanocrystals
- encapsulated fluorescent
- encapsulated
- complexes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/6818—Hybridisation assays characterised by the detection means involving interaction of two or more labels, e.g. resonant energy transfer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
- G01N33/586—Liposomes, microcapsules or cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/588—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with semiconductor nanocrystal label, e.g. quantum dots
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2989—Microcapsule with solid core [includes liposome]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2991—Coated
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2991—Coated
- Y10T428/2993—Silicic or refractory material containing [e.g., tungsten oxide, glass, cement, etc.]
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Nanotechnology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Materials Engineering (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Luminescent Compositions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Provided are a functionalized, encapsulated fluorescent nanocrystal comprising a liposome having encapsulated therein one or more fluorescent nanocrystals; use of the functionalized, encapsulated fluorescent nanocrystals in detection systems; and a method of producing functionalized, encapsulated fluorescent nanocrystals. A method of using the functionalized encapsulated fluorescent nanocrystals having affinity molecule bound thereto comprises contacting the functionalized encapsulated fluorescent nanocrystals with a sample so that complexes are formed between the functionalized encapsulated fluorescent nanocrystals and substrate for which the affinity molecule has binding specificity, if the substrate is present; exposing the complexes in the detection system to an excitation light source, and detecting a fluorescence peak emitted from the complexes, if present.
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18360800P | 2000-02-18 | 2000-02-18 | |
US18360700P | 2000-02-18 | 2000-02-18 | |
US60183608 | 2000-02-18 | ||
US60183607 | 2000-02-18 | ||
US09/783,469 US6761877B2 (en) | 2000-02-18 | 2001-02-14 | Functionalized encapsulated fluorescent nanocrystals |
US09783469 | 2001-02-14 | ||
PCT/US2001/005108 WO2001061045A1 (en) | 2000-02-18 | 2001-02-16 | Functionalized encapsulated fluorescent nanocrystals |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001237057A1 true AU2001237057A1 (en) | 2001-08-27 |
Family
ID=27391706
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001237057A Abandoned AU2001237057A1 (en) | 2000-02-18 | 2001-02-16 | Functionalized encapsulated fluorescent nanocrystals |
Country Status (6)
Country | Link |
---|---|
US (3) | US6761877B2 (en) |
EP (1) | EP1266032B1 (en) |
AT (1) | ATE383440T1 (en) |
AU (1) | AU2001237057A1 (en) |
DE (1) | DE60132311T2 (en) |
WO (1) | WO2001061045A1 (en) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6761877B2 (en) * | 2000-02-18 | 2004-07-13 | Biocrystal, Ltd. | Functionalized encapsulated fluorescent nanocrystals |
US20050059031A1 (en) * | 2000-10-06 | 2005-03-17 | Quantum Dot Corporation | Method for enhancing transport of semiconductor nanocrystals across biological membranes |
WO2002029410A2 (en) * | 2000-10-06 | 2002-04-11 | Quantum Dot Corporation | Cells having a spectral signature, and methods of preparation and use thereof |
JP2003028797A (en) * | 2001-07-11 | 2003-01-29 | Hitachi Software Eng Co Ltd | Fluorescence reader |
JP4072994B2 (en) * | 2001-10-11 | 2008-04-09 | 学校法人日本大学 | Magnetic particles |
JP3701622B2 (en) | 2002-03-27 | 2005-10-05 | 日立ソフトウエアエンジニアリング株式会社 | Semiconductor nanoparticle fluorescent reagent and fluorescence measuring method |
JP3955225B2 (en) * | 2002-03-27 | 2007-08-08 | 日立ソフトウエアエンジニアリング株式会社 | Method for measuring reaction of reaction using semiconductor nanoparticles and method for evaluating quality of semiconductor nanoparticles using the measurement method |
JP3847677B2 (en) | 2002-07-23 | 2006-11-22 | 日立ソフトウエアエンジニアリング株式会社 | Semiconductor nanoparticle, method for producing the same, and semiconductor nanoparticle fluorescent reagent |
JP2004077389A (en) * | 2002-08-21 | 2004-03-11 | Hitachi Software Eng Co Ltd | Functional fluorescent reagent containing semiconductor nanoparticle |
US20050032246A1 (en) * | 2002-11-14 | 2005-02-10 | Mcmaster University | Method of immobilizing membrane-associated molecules |
US8367324B2 (en) * | 2003-11-17 | 2013-02-05 | Canon Kabushiki Kaisha | Method for judging change in probe-bearing substrate, probe-bearing substrate and detecting apparatus |
JP4528990B2 (en) * | 2003-12-09 | 2010-08-25 | 学校法人慶應義塾 | Lipid bilayer and nano-sized phosphor complex |
GB0400235D0 (en) * | 2004-01-07 | 2004-02-11 | Univ Sunderland | Nanoparticles as agents for imaging finger prints |
US20060014175A1 (en) * | 2004-05-17 | 2006-01-19 | Imad Naasani | Functionalized fluorescent nanocrystal detection system |
US7794600B1 (en) * | 2004-08-27 | 2010-09-14 | Nanosys, Inc. | Purification of nanocrystal solutions by chromatography |
US8486371B2 (en) * | 2004-09-17 | 2013-07-16 | The Regents Of The University Of Michigan | Quantitative two-photon flow cytometry |
US20060240227A1 (en) * | 2004-09-23 | 2006-10-26 | Zhijun Zhang | Nanocrystal coated surfaces |
EP1809720B1 (en) * | 2004-10-29 | 2012-05-02 | Life Technologies Corporation | Functionalized fluorescent nanocrystals, and methods for their preparation and use |
WO2006084248A2 (en) * | 2005-02-04 | 2006-08-10 | Antigenics, Inc. | Compositions comprising a platinum complex, lipid, and surfactant |
GB2441666B (en) * | 2005-04-25 | 2010-12-29 | Univ Arkansas | Doped semiconductor nanocrystals and methods of making same |
CA2617513A1 (en) | 2005-08-09 | 2007-02-15 | University Of Sunderland | Fingerprint analysis using mass spectrometry |
US8101430B2 (en) | 2005-08-15 | 2012-01-24 | Massachusetts Institute Of Technology | Fluorescent sensor based on two fluorescent moieties one of which is a semiconductor nanocrystal and methods of using and making |
US8465983B1 (en) * | 2005-08-19 | 2013-06-18 | Gabriel P. Lopez | Detection and delivery systems utilizing supported lipid bilayers |
WO2007030521A1 (en) * | 2005-09-06 | 2007-03-15 | Invitrogen Corporation | Control of chemical modification |
JP4415972B2 (en) * | 2005-09-22 | 2010-02-17 | ソニー株式会社 | Method for producing metal oxide nanoparticles |
US8337721B2 (en) | 2005-12-02 | 2012-12-25 | Vanderbilt University | Broad-emission nanocrystals and methods of making and using same |
PT1962805T (en) | 2005-12-08 | 2016-10-05 | Insmed Inc | Lipid-based compositions of antiinfectives for treating pulmonary infections |
WO2008039912A2 (en) * | 2006-09-27 | 2008-04-03 | Evident Technologies | Retro-emission systems comprising microlens arrays and luminescent emitters |
US9119783B2 (en) | 2007-05-07 | 2015-09-01 | Insmed Incorporated | Method of treating pulmonary disorders with liposomal amikacin formulations |
FR2918755B1 (en) * | 2007-07-09 | 2009-10-30 | Commissariat Energie Atomique | METHOD FOR DETECTING AND QUANTIFYING SOLID - SUPPORTED ANALYTES WITH FLUORESCENT MOLECULES ENCAPSULATED IN IMMUNOLIPOSOMES. |
US20090171330A1 (en) * | 2007-12-28 | 2009-07-02 | Spectranetics | Tunable nanoparticle tags to enhance tissue recognition |
US20090270269A1 (en) * | 2008-04-28 | 2009-10-29 | Ashok Kumar | Nano-scale fluoro-biosensors exhibiting a low false alarm rate for rapid detection of biological contaminants |
WO2009152265A1 (en) * | 2008-06-10 | 2009-12-17 | The Board Of Trustees Of The University Of Arkansas | Indium arsenide nanocrystals and methods of making the same |
US20120034156A1 (en) * | 2010-08-03 | 2012-02-09 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Artificial cells |
US8895158B2 (en) | 2011-08-10 | 2014-11-25 | The Johns Hopkins University | Nanoparticle taggants for explosive precursors |
WO2013078252A1 (en) | 2011-11-22 | 2013-05-30 | Qd Vision, Inc. | Quantum dot-containing compositions including an emission stabilizer, products including same, and method |
WO2013163407A1 (en) * | 2012-04-25 | 2013-10-31 | Trustees Of Tufts College | Silk microspheres and methods for surface lubrication |
MX2015006681A (en) | 2012-11-29 | 2016-04-06 | Insmed Inc | Stabilized vancomycin formulations. |
US20160145679A1 (en) * | 2013-03-01 | 2016-05-26 | Arizona Board Of Regents On Behalf Of Arizona State University | Oligonucleotide functionalized quantum dots |
US9229611B2 (en) * | 2013-03-05 | 2016-01-05 | Oracle International Corporation | Automatic management of client data consistency |
CA2943049A1 (en) | 2014-04-08 | 2015-10-15 | Aradigm Corporation | Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria |
KR20160144404A (en) | 2014-04-08 | 2016-12-16 | 아라다임 코포레이션 | Liposomes that form drug nanocrystals after freeze-thaw |
WO2015175939A1 (en) | 2014-05-15 | 2015-11-19 | Insmed Incorporated | Methods for treating pulmonary non-tuberculous mycobacterial infections |
WO2017147407A1 (en) * | 2016-02-25 | 2017-08-31 | Board Of Regents, The University Of Texas System | Compositions comprising composite nanocarriers and methods of making and uses thereof |
EP3773505A4 (en) | 2018-03-30 | 2021-12-22 | Insmed Incorporated | Methods for continuous manufacture of liposomal drug products |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4614796A (en) * | 1983-03-25 | 1986-09-30 | Nippon Shinyaku Co., Ltd. | Liposome and method of manufacture therefor |
AU7359487A (en) * | 1986-05-30 | 1987-12-22 | Johns Hopkins University, The | Receptor-targeted drug delivery systems |
CA1340806C (en) * | 1986-07-02 | 1999-11-02 | James Merrill Prober | Method, system and reagents for dna sequencing |
US5151507A (en) * | 1986-07-02 | 1992-09-29 | E. I. Du Pont De Nemours And Company | Alkynylamino-nucleotides |
US5227489A (en) * | 1988-08-01 | 1993-07-13 | Ciba Corning Diagnostics Corp. | Stable hydrophilic acridinium esters suitable for liposome encapsulation |
US5578718A (en) * | 1990-01-11 | 1996-11-26 | Isis Pharmaceuticals, Inc. | Thiol-derivatized nucleosides |
US5187085A (en) * | 1990-09-28 | 1993-02-16 | Applied Biosystems, Inc. | Nucleic acid sequence analysis with nucleoside-5'-o-(1-thiotriphosphates) |
YU187991A (en) * | 1990-12-11 | 1994-09-09 | Hoechst Aktiengesellschaft | 3- (2) -AMINO-ALI THIOL-MODIFIED, FLUORESCENT-DYED NUCLEOSIDES, NUCLEOTIDS AND OLIGONUCLEOTIDES, PROCESS FOR THEIR OBTAINING AND THEIR USE |
US5364759B2 (en) * | 1991-01-31 | 1999-07-20 | Baylor College Medicine | Dna typing with short tandem repeat polymorphisms and identification of polymorphic short tandem repeats |
US5650277A (en) * | 1992-07-02 | 1997-07-22 | Diagenetics Ltd. | Method of determining the presence and quantifying the number of di- and trinucleotide repeats |
US6048616A (en) | 1993-04-21 | 2000-04-11 | Philips Electronics N.A. Corp. | Encapsulated quantum sized doped semiconductor particles and method of manufacturing same |
US5637258A (en) * | 1996-03-18 | 1997-06-10 | Nanocrystals Technology L.P. | Method for producing rare earth activited metal oxide nanocrystals |
JP4245664B2 (en) * | 1996-07-29 | 2009-03-25 | ナノスフェアー インコーポレイテッド | Method for detecting the target acid using gold nanoparticles with oligonucleotides |
DE19724796A1 (en) * | 1997-06-06 | 1998-12-10 | Max Delbrueck Centrum | Antitumor therapy agents |
US5990479A (en) | 1997-11-25 | 1999-11-23 | Regents Of The University Of California | Organo Luminescent semiconductor nanocrystal probes for biological applications and process for making and using such probes |
US6207392B1 (en) * | 1997-11-25 | 2001-03-27 | The Regents Of The University Of California | Semiconductor nanocrystal probes for biological applications and process for making and using such probes |
US6114038A (en) | 1998-11-10 | 2000-09-05 | Biocrystal Ltd. | Functionalized nanocrystals and their use in detection systems |
WO2000028089A1 (en) | 1998-11-10 | 2000-05-18 | Biocrystal Limited | Functionalized nanocrystals and their use in labeling for strand synthesis or sequence determination |
US6221602B1 (en) * | 1998-11-10 | 2001-04-24 | Bio-Pixels Ltd. | Functionalized nanocrystals and their use in labeling for strand synthesis or sequence determination |
US6194213B1 (en) * | 1999-12-10 | 2001-02-27 | Bio-Pixels Ltd. | Lipophilic, functionalized nanocrystals and their use for fluorescence labeling of membranes |
US6179912B1 (en) * | 1999-12-20 | 2001-01-30 | Biocrystal Ltd. | Continuous flow process for production of semiconductor nanocrystals |
US6761877B2 (en) * | 2000-02-18 | 2004-07-13 | Biocrystal, Ltd. | Functionalized encapsulated fluorescent nanocrystals |
-
2001
- 2001-02-14 US US09/783,469 patent/US6761877B2/en not_active Expired - Lifetime
- 2001-02-16 AU AU2001237057A patent/AU2001237057A1/en not_active Abandoned
- 2001-02-16 DE DE60132311T patent/DE60132311T2/en not_active Expired - Lifetime
- 2001-02-16 EP EP01909283A patent/EP1266032B1/en not_active Expired - Lifetime
- 2001-02-16 AT AT01909283T patent/ATE383440T1/en not_active IP Right Cessation
- 2001-02-16 WO PCT/US2001/005108 patent/WO2001061045A1/en active Search and Examination
-
2004
- 2004-06-14 US US10/866,929 patent/US7060252B2/en not_active Expired - Lifetime
-
2005
- 2005-12-12 US US11/301,050 patent/US7244413B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US7060252B2 (en) | 2006-06-13 |
US20020001716A1 (en) | 2002-01-03 |
EP1266032B1 (en) | 2008-01-09 |
US20060099147A1 (en) | 2006-05-11 |
US6761877B2 (en) | 2004-07-13 |
DE60132311D1 (en) | 2008-02-21 |
EP1266032A4 (en) | 2005-01-19 |
US7244413B2 (en) | 2007-07-17 |
WO2001061045A1 (en) | 2001-08-23 |
ATE383440T1 (en) | 2008-01-15 |
US20050019486A1 (en) | 2005-01-27 |
EP1266032A1 (en) | 2002-12-18 |
DE60132311T2 (en) | 2009-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001237057A1 (en) | Functionalized encapsulated fluorescent nanocrystals | |
DE60234382D1 (en) | NANO CRYSTALS | |
AU6779700A (en) | Microparticles with multiple fluorescent signals and methods of using same | |
ATE317122T1 (en) | FLUORESCENT POLARIZATION | |
JP2005513471A5 (en) | ||
ATE342508T1 (en) | CAPSULES CONTAINING SOLID PARTICLES OF SIGNAL-GENERATING ORGANIC SUBSTANCES | |
DE69735532D1 (en) | DETERMINATION OF ANTIGENS BY OLIGONUCLEOTIDE ANTIBODY CONJUGATES | |
AU2001242345A1 (en) | Method and device for detecting temperature-dependent parameters, such as association/dissociation parameters and/or the equilibrium constant of complexes that comprise at least two components | |
DE60136034D1 (en) | Molecular modification assays | |
CA2231186A1 (en) | Optical apparatus for performing an immunoassay | |
CA2366303A1 (en) | Semiconductor nanocrystal probes for biological applications | |
WO2001086299A3 (en) | Doped nanoparticles as biolabels | |
AU3659002A (en) | Methods, circuits and compositions of matter for in vivo detection of biomolecule concentrations using fluorescent tags | |
DE50210457D1 (en) | DEVICE FOR REFERENCING FLUORESCENT SIGNALS | |
PL368690A1 (en) | Method for detecting analyte(s) using magnetic colloidal particles | |
AU7532501A (en) | Method for increasing luminescence assay sensitivity | |
WO2006014576A3 (en) | Fluorescent lifetime biological detection and imaging using water-stable semiconductor nanocrystals | |
DE69604920D1 (en) | USE OF A PHYCOBILIPROTEIN-PEPTIDE COMPLEX COMPOUND AS A FLUORESCENT LABEL | |
WO2002035228A3 (en) | Method and test kit for detecting analytes in a sample | |
DE69732034D1 (en) | ASSAY METHOD | |
AU2002245206A1 (en) | Dendritic chemiluminescent substrates | |
AU2002312899A1 (en) | Hybrid method for the production of carriers for analyte determination | |
ATE336572T1 (en) | NEW REAGENTS IN CHEMILUMINESCENCE DETECTION METHODS | |
AU3297000A (en) | Method for reducing fluorescence quenching in bioassays | |
DE60332479D1 (en) | HOLO-TRANSCOBALAMIN BINDING PARTNER AND ITS USE IN COBALAMINTEST |